Eli Lilly and its rivals are working to develop more convenient options than the injectable Zepbound and Wegovy, which ...

The use of GLP-1 drugs sparked the term "Ozempic shaming" to describe the negative perceptions faced by those who choose ...

Eli Lilly & Co. (LLY) thinks its next experimental weight-loss pill could get approved as soon as early 2026. CEO Dave Ricks ...

Weight-loss supplements promise quick results but often lack scientific backing. Popular ingredients like caffeine, green tea ...

Eli Lilly & Co. (LLY) thinks its next experimental weight-loss pill could get approved as soon as early 2026. CEO Dave Ricks told Bloomberg News on Monday that data on the drug, orforglipron, is ...

While cinnamon and honey water can be tasty and beneficial additions to your diet, it’s essential to recognize that they are ...

Diet and weight loss often go hand in hand. Celebrity nutritionist Rujuta Diwekar highlights the kinds of diets that may not ...

Eli Lilly expects its experimental weight loss pill, orforglipron, to receive approval as early as next year, CEO David Ricks told Bloomberg Jan. 13, according to a Wall Street Journal report.

Eli Lilly expects its experimental weight loss pill, orforglipron, to be approved as soon as early next year, CEO David Ricks told Bloomberg. Eli Lilly and Novo Nordisk, which dominate the market ...

The best semaglutide dose for weight loss varies according to your starting weight, risks, and stage of treatment. Read to ...

A little over two years ago, a whisper of a new drug was abundant. Ozempic was quickly deemed a “miracle” medication, though few could predict how quickly and vastly it would revolutionise the ...